Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
ServiceNow
NOW
|
$1.13B |
| 2 |
Meta Platforms (Facebook)
META
|
$1.12B |
| 3 |
Advanced Micro Devices
AMD
|
$1.06B |
| 4 |
MongoDB
MDB
|
$817M |
| 5 |
Ulta Beauty
ULTA
|
$477M |
Top Sells
| 1 |
Danaher
DHR
|
$1.27B |
| 2 |
T-Mobile US
TMUS
|
$1.03B |
| 3 |
Schlumberger
SLB
|
$964M |
| 4 |
Thermo Fisher Scientific
TMO
|
$829M |
| 5 |
Atlassian
TEAM
|
$819M |
Sector Composition
| 1 | Technology | 38.76% |
| 2 | Consumer Discretionary | 19.8% |
| 3 | Healthcare | 13.64% |
| 4 | Financials | 8.74% |
| 5 | Communication Services | 8.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMK
201
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $45.3M | 0.04% |
1,528,327
+573,517
| +60% | +$17M |
|
202
Celldex Therapeutics
CLDX
$1.57B
| $45.1M | 0.04% |
1,329,095
-252,995
| -16% | -$8.58M |
|
203
Pinterest
PINS
$25.2B
| $44.8M | 0.04% |
1,638,680
+335,269
| +26% | +$9.17M |
|
204
Fortive
FTV
$15.9B
| $44.2M | 0.04% |
590,613
-5,570
| -0.9% | -$416K |
|
205
CoStar Group
CSGP
$37.2B
| $43.9M | 0.04% |
493,465
-92,951
| -16% | -$8.27M |
|
206
Shell
SHEL
$211B
| $43.6M | 0.04% |
721,499
+138,689
| +24% | +$8.37M |
|
207
Abbott
ABT
$230B
| $43.2M | 0.04% |
396,497
-3,137,997
| -89% | -$342M |
|
208
Datadog
DDOG
$46.2B
| $43.2M | 0.04% |
439,322
-29,778
| -6% | -$2.93M |
|
|
CDMO
209
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $43.2M | 0.04% |
3,091,844
+149,268
| +5% | +$2.09M |
|
210
Marvell Technology
MRVL
$53.7B
| $42.7M | 0.04% |
714,077
-73,332
| -9% | -$4.38M |
|
211
Sun Country Airlines
SNCY
$720M
| $42.6M | 0.03% |
1,894,717
+94,773
| +5% | +$2.13M |
|
212
XP
XP
$9.38B
| $42.4M | 0.03% |
+1,808,775
| New | +$42.4M |
|
213
Exact Sciences
EXAS
$9.33B
| $42.4M | 0.03% |
451,181
+12,247
| +3% | +$1.15M |
|
214
Energy Recovery
ERII
$750M
| $42.3M | 0.03% |
1,513,383
+172,914
| +13% | +$4.83M |
|
215
East-West Bancorp
EWBC
$14.7B
| $42.2M | 0.03% |
800,249
+76,595
| +11% | +$4.04M |
|
216
Arcutis Biotherapeutics
ARQT
$1.91B
| $40.9M | 0.03% |
4,293,966
+2,079,476
| +94% | +$19.8M |
|
|
ROIC
217
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $40.7M | 0.03% |
3,009,006
-94,709
| -3% | -$1.28M |
|
218
Hilltop Holdings
HTH
$2.21B
| $40.6M | 0.03% |
1,291,890
+157,704
| +14% | +$4.96M |
|
219
Apollo Global Management
APO
$75.9B
| $39.8M | 0.03% |
518,031
-94,243
| -15% | -$7.24M |
|
220
Eastern Bankshares
EBC
$3.38B
| $39.8M | 0.03% |
3,240,066
+393,261
| +14% | +$4.83M |
|
221
Diamondback Energy
FANG
$41.2B
| $39.5M | 0.03% |
300,501
+924
| +0.3% | +$121K |
|
|
RCM
222
DELISTED
R1 RCM Inc. Common Stock
RCM
| $39.3M | 0.03% |
2,127,373
+165,433
| +8% | +$3.05M |
|
223
TotalEnergies
TTE
$135B
| $39.1M | 0.03% |
678,723
+976
| +0.1% | +$56.3K |
|
224
Pacira BioSciences
PCRX
$1.22B
| $38.7M | 0.03% |
965,430
+139,593
| +17% | +$5.59M |
|
225
CBRE Group
CBRE
$47.3B
| $38.5M | 0.03% |
477,390
-146,425
| -23% | -$11.8M |
|